Dharmalingam, Mala

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Dharmalingam, M., & Yamasandhi, P. (2018) · Indian Journal of Endocrinology and Metabolism

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 239

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H., Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., et al. (2019) · The Lancet Diabetes & Endocrinology

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 169

Digital twin-enabled personalized nutrition improves metabolic dysfunction-associated fatty liver disease in type 2 diabetes: results of a 1-year randomized controlled study

Joshi, S., Shamanna, P., Dharmalingam, M., Vadavi, A., Keshavamurthy, A., Shah, L., & Mechanick, J. I. (2023) · Endocrine Practice

Nutrition, Genetics, and DiseaseDiabetes Management and Research

Cited by 81

Triple oral fixed‐dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study‐II)

Bell, D. S. H., Dharmalingam, M., Kumar, S., & Sawakhande, R. B. (2011) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 28

Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial

Ali, M. K., Singh, K., Kondal, D., Devarajan, R., Patel, S. A., Menon, V. U., Varthakavi, P. K., Vishwanathan, V., Dharmalingam, M., Bantwal, G., et al. (2024) · PLOS Medicine

Diabetes Management and EducationDiabetes Treatment and Management

Cited by 10

1706999 the impact of digital twin technology on hbA1c reduction and ASCVD risk in participants enrolled for type 2 diabetes remission: outcomes of RCCT at 1 year

Shamanna, P., Shamanna, P., Dharmalingam, M., Vadavi, A., Keshavamurthy, A., Thajudeen, M., Bhonsley, S., & Joshi, S. (2024) · Endocrine Practice

Mobile Health and mHealth ApplicationsDiabetes Management and Research

Cited by 3

1707108 impact of digital twin intervention on microalbuminuria progression in participants enrolled for type 2 diabetes remission: outcomes of RCCT at 1 year

Shamanna, P., Joshi, S., Dharmalingam, M., Vadavi, A., Keshavamurthy, A., Thajudeen, M., Bhonsley, S., & Shamanna, P. (2024) · Endocrine Practice

Mobile Health and mHealth ApplicationsDiabetes Management and Research

Cited by 2